secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001193125-25-302552
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage withdraws CIRM grant app for OPC1; plans resubmission Jan 2026
----------------------------------------------------------------------

- Withdrew CIRM CLIN2 grant application on Nov 28 after receiving CIRM comments on Nov 24.
- No content deficiencies identified; intends to submit revised application in next CIRM cycle (Jan 2026).
- Withdrawal does not impact ongoing DOSED clinical study of OPC1 for spinal cord injury.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000119312525302552/0001193125-25-302552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000119312525302552/lctx-20251128.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-302552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer